Patent details

EP4051710 Title: ANTI-TUMOR COMBINATION THERAPY COMPRISING ANTI-CD19 ANTIBODY AND GAMMA DELTA T-CELLS

Basic Information

Publication number:
EP4051710
PCT Application Number:
EP2020080494
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP208001214
PCT Publication Number:
WO2021084063
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-TUMOR COMBINATION THERAPY COMPRISING ANTI-CD19 ANTIBODY AND GAMMA DELTA T-CELLS
French Title of Invention:
THÉRAPIE COMBINÉE ANTITUMORALE COMPRENANT UN ANTICORPS ANTI-CD19 ET DES CELLULES T GAMMA DELTA
German Title of Invention:
ANTI-TUMOR-KOMBINATIONSTHERAPIE, ANTI-CD19-ANTIKÖRPER UND GAMMA-DELTA-T-ZELLEN UMFASSEND
SPC Number:

Dates

Filing date:
30/10/2020
Grant date:
26/11/2025
EP Publication Date:
07/09/2022
PCT Publication Date:
06/05/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/11/2025
EP B1 Publication Date:
26/11/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
30/10/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/11/2025
 
 

Name:
Incyte Corporation
Address:
1801 Augustine Cut-Off, Wilmington, DE 19803, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
02/12/2025
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
ENDELL, Jan
Address:
Germany (DE)

2

Name:
PRETSCHER, Dominik
Address:
Germany (DE)

3

Name:
BOXHAMMER, Rainer
Address:
Germany (DE)

Priority

Priority Number:
19206479
Priority Date:
31/10/2019
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
C07K 16/28; A61K 35/17; A61K 39/395; A61P 35/02; A61K 39/00;

Publication

European Patent Bulletin

1

Issue number:
202548
Publication date:
26/11/2025
Description:
Grant (B1)

2

Issue number:
202601
Publication date:
31/12/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
02/11/2026
Annual Fee Number:
7
Annual Fee Amount:
82 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
02/12/2025 Outgoing Correspondence 1
02/12/2025 Power Of Attorney 1